OXULAR LIMITED

Company number 09331313 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Overview

Company type
Private Limited Company
Incorporated
2014-11-27
Registered office
The Charter Building, Vine Street, Uxbridge, Middlesex, England, UB8 1JG
Postcode
UB8 1JG
Capital
450 GBP
Accounts category
Total Exemption Full
Charges
0 outstanding

Accounts

Last made up to
2024-10-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-11-19
Next due by
2026-12-03
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 7 current · 10 resigned

Mark VOLPE Director
Appointed 2024-12-20
Zoran BERKOVIC Director
Appointed 2024-12-20
Ronald YAMAMOTO Director
Company Director Appointed 2021-08-04
DIRECTOR Appointed 2016-02-20
COMPANY DIRECTOR Appointed 2016-02-20

View all officers and resignations →

Group structure 1 subsidiary

Controlled by Regeneron Pharmaceuticals, Inc. (01226128) — since 2024-12-20

From persons-with-significant-control filings on the public register.

Contact details

Website
oxular.com

Discover how Regeneron (NASDAQ: REGN) uses the power of science to bring new medicines to patients… over and over again.

Previous company names

NameDate changed
PRECISION OCULAR LTD2016-10-10

Previous registered addresses 2

AddressChanged on
MAGDALEN HOUSE 1 ROBERT ROBINSON AVENUE, OXFORD, OX4 4GA, ENGLAND2016-08-12
RIVERBANK HOUSE 2 SWAN LANE, LONDON, EC4R 3TT2016-05-27

At this address

136

companies are registered at this postcode →

The class of 2014

38%

of the 357 companies in this sector incorporated in 2014 are still active today; 59% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →